Comparative Pharmacology
Head-to-head clinical analysis: ISOLYTE E IN PLASTIC CONTAINER versus PLASMA LYTE R IN PLASTIC CONTAINER.
Head-to-head clinical analysis: ISOLYTE E IN PLASTIC CONTAINER versus PLASMA LYTE R IN PLASTIC CONTAINER.
ISOLYTE E IN PLASTIC CONTAINER vs PLASMA-LYTE R IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
ISOLYTE E is an intravenous electrolyte replacement solution that provides water, electrolytes (sodium, potassium, magnesium, calcium, chloride, acetate, and gluconate), and bicarbonate precursors to correct fluid and electrolyte imbalances. The acetate and gluconate ions are metabolized to bicarbonate in the liver, providing an alkaline buffer.
Plasma-Lyte R provides electrolytes and water to maintain or restore fluid balance, with bicarbonate precursors (acetate, gluconate) to buffer metabolic acidosis.
Intravenous infusion; rate and volume determined by individual patient requirements for fluid and electrolyte replacement. Typical adult dose: 500-1000 mL as a single infusion, administered at a rate of 5-10 mL/min.
Intravenous infusion at a rate of 25-50 mL/kg body weight per 24 hours, adjusted for fluid and electrolyte needs. Typical adult maintenance dose: 1-2 L/day.
None Documented
None Documented
Not applicable as a single agent; components have variable half-lives (e.g., sodium and chloride distribute rapidly with an elimination half-life of 2-4 hours depending on renal function). In renal impairment, half-life may be prolonged.
Not applicable (Plasma-Lyte R components are endogenous electrolytes and water; administered crystalloid redistributes rapidly; half-life of approximately 20-30 minutes for volume expansion due to renal excretion and redistribution into interstitial space)
Renal: >95% of administered electrolytes and water are excreted unchanged by the kidneys, primarily as urine. Biliary/fecal: <5% eliminated via feces, mainly unabsorbed components.
Renal: >90% (electrolytes and water); Biliary/fecal: negligible (<5%)
Category C
Category C
Intravenous Electrolyte Solution
Intravenous Electrolyte Solution